Actively monitor private Covid vaccine manufacturers: Kejriwal to Vardhan

Arvind Kejriwal urged the Centre to 'actively monitor and supervise' private Covid-19 vaccine manufacturers in the country and ensure adequate availability of the vaccine doses to states and UTs

Chief Minister Arvind Kejriwal. (PTI photo/ screen grab)
Chief Minister Arvind Kejriwal. (PTI photo/ screen grab)
Press Trust of India New Delhi
1 min read Last Updated : May 09 2021 | 8:19 PM IST

Delhi Chief Minister Arvind Kejriwal urged the Centre to "actively monitor and supervise" private COVID-19 vaccine manufacturers in the country and ensure adequate availability of the vaccine doses to states and Union territories.

The central government should make available to the states/UTs the requisite number of vaccine doses to enable vaccination of all its citizens, he said.

"The Centre should actively monitor and supervise the manufacture of vaccines by the private parties so that supplies in adequate quantity are made to all state governments, and this crucial aspect is not left to the discretion of the private manufacturers, Kejriwal said in a letter to Union Health Minister Harsh Vardhan.

The Delhi CM also said that a uniform price should be fixed for the vaccines for supplies made to governments (whether central or states) and private hospitals.

Kejriwal has reiterated on several occasions that his government can vaccinate everyone in the national capital within three months if the Centre ensures supply of adequate doses of vaccine to it.

He has claimed Delhi needs 3 crore doses, out of which, only around 40 lakh doses have been received by it so far.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Arvind KejriwalCoronavirusCoronavirus VaccineHarsh Vardhan

First Published: May 09 2021 | 8:16 PM IST

Next Story